Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021

The safety profile of the 9-valent human papillomavirus vaccine (9vHPV) was evaluated based on the reporting rate of adverse events following immunization (AEFI) obtained from the passive surveillance data in Zhejiang. The 9vHPV AEFI reports in Zhejiang were collected and reviewed from the National...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fuxing, Pan, Xuejiao, Liang, Hui, Shen, Lingzhi, Wang, Ying, Chen, Yaping, Lv, Huakun, Hu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762803/
https://www.ncbi.nlm.nih.gov/pubmed/36484114
http://dx.doi.org/10.1080/21645515.2022.2152256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762803/
https://www.ncbi.nlm.nih.gov/pubmed/36484114
http://dx.doi.org/10.1080/21645515.2022.2152256

Ejemplares similares